ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Weicker Heads New Group For More Spending On Medical Research; Committee Oks Sullivan

March 3, 1989

Funding Opportunities (8-page issue).

May 23, 2003

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012